Johnson & Johnson (LIM:JNJ) Total Stockholders Equity : $78,109 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Total Stockholders Equity?

Johnson & Johnson's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $78,109 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Johnson & Johnson's Book Value per Share for the quarter that ended in Mar. 2025 was $32.47. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Johnson & Johnson's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.67.

Johnson & Johnson Total Stockholders Equity Historical Data

The historical data trend for Johnson & Johnson's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Total Stockholders Equity Chart

Johnson & Johnson Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

63,278.00

74,023.00

76,804.00

68,774.00

71,490.00

Johnson & Johnson Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															70,020.00	71,538.00	70,158.00	71,490.00	78,109.00

Johnson & Johnson (LIM:JNJ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Johnson & Johnson's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(78109	-	0)	/	2405.625
	=	32.47

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Johnson & Johnson's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13897	+	38355)	/	78109
	=	0.67

Johnson & Johnson Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (LIM:JNJ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria JNJ:Argentina

Address

One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.